Early Warning Systems for Emerging Profiles of Antimicrobial Resistance in Italy: A National Survey.

antimicrobial resistance early warning system emerging antimicrobial resistance surveillance

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
24 04 2023
Historique:
received: 03 03 2023
revised: 14 04 2023
accepted: 21 04 2023
medline: 15 5 2023
pubmed: 13 5 2023
entrez: 13 5 2023
Statut: epublish

Résumé

Antimicrobial resistance (AMR) national surveillance systems in Italy lack alert systems for timely detection of emerging profiles of AMR with potential relevance to public health. Furthermore, the existence of early warning systems (EWS) at subnational level is unclear. This study aims at mapping and characterizing EWS for microbiological threats available at regional level in Italy, focusing on emerging AMR, and at outlining potential barriers and facilitators to their development/implementation. To this end, a three-section, web-based survey was developed and administered to all Italian regional AMR representatives from June to August 2022. Twenty out of twenty-one regions and autonomous provinces (95.2%) responded to the survey. Among these, nine (45%) reported the implementation of EWS for microbiological threats at regional level, three (15%) reported that EWS are in the process of being developed, and eight (40%) reported that EWS are not currently available. EWS characteristics varied widely among the identified systems concerning both AMR profiles reported and data flow: the microorganisms most frequently included were extensively drug-resistant (XDR)

Identifiants

pubmed: 37174143
pii: ijerph20095623
doi: 10.3390/ijerph20095623
pmc: PMC10178630
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Epidemiol Prev. 2019 Mar-Jun;43(2-3):185-193
pubmed: 31293138
Front Med (Lausanne). 2021 Apr 19;8:652638
pubmed: 33954161
Health Econ Policy Law. 2014 Jul;9(3):231-49
pubmed: 24507728
Lancet Infect Dis. 2018 Mar;18(3):e99-e106
pubmed: 29102325
Lancet Glob Health. 2023 Mar;11(3):e466-e474
pubmed: 36739875
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683

Auteurs

Jessica Iera (J)

Management and Health Laboratory, Institute of Management, Department EMbeDS, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy.
Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Chiara Seghieri (C)

Management and Health Laboratory, Institute of Management, Department EMbeDS, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy.

Lara Tavoschi (L)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Claudia Isonne (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Department of Infectious Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy.

Valentina Baccolini (V)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Daniele Petrone (D)

Department of Infectious Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy.
Department of Statistics, Sapienza University of Rome, 00185 Rome, Italy.

Antonella Agodi (A)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.

Martina Barchitta (M)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123 Catania, Italy.

Luca Arnoldo (L)

Department of Medicine, University of Udine, 33100 Udine, Italy.
Accreditation and Quality Unit, Friuli Centrale Healthcare University Trust, 33100 Udine, Italy.

Roberta Creti (R)

Department of Infectious Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy.

Silvia Forni (S)

Regional Health Agency of Tuscany, 50139 Florence, Italy.

Annibale Raglio (A)

Division of Microbiology and Virology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Enrico Ricchizzi (E)

Regional Health and Social Agency, Emilia Romagna Region, 40127 Bologna, Italy.

Lorenzo Bandini (L)

Department of Infectious Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy.

Adriano Grossi (A)

Department of Infectious Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy.

Fortunato D'Ancona (F)

Department of Infectious Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
1.00
Humans Female Sick Leave Norway Sinusitis
Humans Mobile Applications Hepatitis C Male Female
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Classifications MeSH